In conclusion, higher SNE may be associated with lower cognitive decline in cognitively healthy elderly and patients of MCI, especially so at the earlier stages of the AD biomarker cascade characterized by increased amounts of baseline cerebral amyloid load and low amounts of baseline CSF tau. Here, MAPT is linked to Alzheimer disease.